What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?

被引：0
|
作者：
Weiss, R. [1 ]
Griffin, M. L. [1 ]
机构：
[1] Harvard Med Sch, Psychiat Div Alcohol Drugs & Addict, McLean Hosp, Belmont, MA USA
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.1196
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0916
引用
下载
收藏
页码：S569 / S570
页数：2
相关论文
共 50 条
  • [21] Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
    Sanger, Nitika
    Bhatt, Meha
    Zielinski, Laura
    Sanger, Stephanie
    Shahid, Hamnah
    Bantoto, Bianca
    Samaan, M. Constantine
    de Souza, Russell
    Samaan, Zainab
    SYSTEMATIC REVIEWS, 2018, 7
  • [22] SAFETY AND PRELIMINARY OUTCOMES OF SHORT-ACTING OPIOID AGONIST TREATMENT (SOAT) FOR HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER
    Thakrar, Ashish P.
    Uritsky, Tanya J.
    Christopher, Cara
    Winston, Anna
    Ronning, Kaitlin
    Sigueza, Anna Lee
    Caputo, Anne L.
    McFadden, Rachel
    Olenik, Jennifer
    Perrone, Jeanmarie
    Delgado, M. K.
    Lowenstein, Margaret
    Compton, Peggy
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S321 - S321
  • [23] Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
    Thakrar, Ashish P.
    Uritsky, Tanya J.
    Christopher, Cara
    Winston, Anna
    Ronning, Kaitlin
    Sigueza, Anna Lee
    Caputo, Anne
    McFadden, Rachel
    Olenik, Jennifer M.
    Perrone, Jeanmarie
    Delgado, M. Kit
    Lowenstein, Margaret
    Compton, Peggy
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [24] Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
    Anne Berit Bech
    Thomas Clausen
    Helge Waal
    Jūratė Šaltytė Benth
    Ivar Skeie
    BMC Health Services Research, 19
  • [25] Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
    Ashish P. Thakrar
    Tanya J. Uritsky
    Cara Christopher
    Anna Winston
    Kaitlin Ronning
    Anna Lee Sigueza
    Anne Caputo
    Rachel McFadden
    Jennifer M. Olenik
    Jeanmarie Perrone
    M. Kit Delgado
    Margaret Lowenstein
    Peggy Compton
    Addiction Science & Clinical Practice, 18
  • [26] Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder
    Brothers, Thomas D.
    Fraser, John
    MacAdam, Emily
    Morgan, Brendan
    Webster, Duncan
    DRUG AND ALCOHOL REVIEW, 2022, 41 (02) : 430 - 434
  • [27] Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
    Bech, Anne Berit
    Clausen, Thomas
    Waal, Helge
    Benth, Jurate Saltyte
    Skeie, Ivar
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
  • [28] The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder
    Mojtabai, Ramin
    Mauro, Christine
    Wall, Melanie M.
    Barry, Colleen L.
    Olfson, Mark
    PSYCHIATRIC SERVICES, 2019, 70 (07) : 617 - 620
  • [29] Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder
    Bhatraju, Elenore P.
    Radick, Andrea C.
    Leroux, Brian G.
    Kim, Theresa W.
    Samet, Jeffrey H.
    Tsui, Judith I.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2023, 49 (04): : 511 - 518
  • [30] Characterizing Methamphetamine Use Among Opioid Agonist Therapy-Seeking Adults With Prescription-Type Opioid Use Disorder in Canada
    Langlois, Jenna
    Fairbairn, Nadia
    Jutras-Aswad, Didier
    Le Foll, Bernard
    Lim, Ron
    Socias, M. Eugenia
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
12345